Radiaction Medical has secured an additional 510(k) clearance for its Radiation Shielding System from the US Food and Drug Administration (FDA).

This clearance enables the use of the system with the Siemens Artis family of fluoroscopy C-arm machines.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Introduced earlier in the year, the Shield System works as an accessory to new and legacy Artis C-arm models.

It is a completely automated and integrated, head-to-toe shielding device, which has been designed to block radiation scatter at its source.

This latest authorisation builds on the device’s previous clearance with Toshiba Infinix-I systems.

It also allows the Shield System to be leveraged in several interventional cardiology and electrophysiology laboratories in the US.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

This expands the availability of the Radiation Shielding System to more physicians and staff.

Radiaction Medical CEO Jonathan Yifat said: “The reactions to our Shield System technology and capabilities have been extremely encouraging.

“Awareness has been growing about the negative implications of staff radiation exposure in interventional labs, but until now, there was no meaningful, comprehensive way to address the problem.

“We are now in a historic position and uniquely poised to drive a truly novel, integrated and automated solution to market, and directly into the hands of the dedicated healthcare providers at all levels delivering top-tier patient care.”

According to the company, its protection technology blocks radiation exposure for staff and avoids the limitations of currently available solutions.

These limitations include gaps in complete body coverage, resulting in reduced protection to staff, and creating obstructions that limit patient access.

Clinical studies have also demonstrated that Radiaction’s Shield System can reduce radiation scatter to the complete interventional lab by more than 90%.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact